Evidence map›Paper›PMID 31597663›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Metformin Abrogates Age-Associated Ovarian Fibrosis.

Curtis W McCloskey, David P Cook, Brendan S Kelly, Feryel Azzi, Christian H Allen, Amanda Forsyth, Jeremy Upham, Katey J Rayner, Douglas A Gray, Robert W Boyd and 5 more

Registry-linked trialAbstract readComment
PubMed Publisher
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05317806 (Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population), which is not on this map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05317806 phase4active not recruitingnot on this mapstarted 2022, after this paper: background citation

Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population

TypeinterventionalSponsorIndiana Hemophilia &Thrombosis Center, Inc.Ran2022 to 2027Enrolled15ConditionsPlasminogen Activator Inhibitor-1 Deficiency, Cardiac FibrosisArmsMetformin Extended Release Oral Tablet
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Molecular mechanisms of ovarian fibrosis.Molecular human reproduction · 2026
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Curtis W McCloskeyCancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.ORCID 0000-0002-3481-2221
David P CookCancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.ORCID 0000-0001-7639-6724
Brendan S KellyCancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.
Feryel AzziInstitut du Cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
Christian H AllenDepartment of Physics, Carleton University, Ottawa, Ontario, Canada.
Amanda ForsythDepartment of Obstetrics and Gynecology, University of Ottawa, Ottawa, Ontario, Canada.
Jeremy UphamDepartment of Physics and School of Electrical Engineering and Computer Science, University of Ottawa, Ottawa, Canada.
Katey J RaynerUniversity of Ottawa Heart Institute, Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, Ottawa, Ontario, Canada.
Douglas A GrayCancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.ORCID 0000-0002-8634-4984
Robert W BoydDepartment of Physics and School of Electrical Engineering and Computer Science, University of Ottawa, Ottawa, Canada.
Sangeeta MurugkarDepartment of Physics, Carleton University, Ottawa, Ontario, Canada.
Bryan LoCancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.
Dominique TrudelInstitut du Cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.ORCID 0000-0001-9820-1772
Mary K SentermanDepartment of Obstetrics and Gynecology, University of Ottawa, Ottawa, Ontario, Canada.
Barbara C VanderhydenCancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada. bvanderhyden@ohri.ca.ORCID 0000-0002-7644-7189
University of Ottawa · CACarleton University · CACentre Hospitalier de l’Université de Montréal · CAOttawa Hospital · CA

Funding

CIHR MOP136829
6 · The paper itself

Abstract

purposeThe ovarian cancer risk factors of age and ovulation are curious because ovarian cancer incidence increases in postmenopausal women, long after ovulations have ceased. To determine how age and ovulation underlie ovarian cancer risk, we assessed the effects of these risk factors on the ovarian microenvironment. EXPERIMENTAL

designAged C57/lcrfa mice (0-33 months old) were generated to assess the aged ovarian microenvironment. To expand our findings into human aging, we assembled a cohort of normal human ovaries (

resultsWe first validated the presence of age-associated murine ovarian fibrosis. Using interdisciplinary methodologies, we provide novel evidence that ovarian fibrosis also develops in human postmenopausal ovaries across two independent cohorts (

conclusionsThese data support a novel hypothesis that unifies the primary nonhereditary ovarian cancer risk factors through the development of ovarian fibrosis and the formation of a premetastatic niche, and suggests a potential use for metformin in ovarian cancer prophylaxis.

Indexed as

Carcinoma, Ovarian EpithelialMetforminOvarian NeoplasmsAdultAgedAged, 80 and overAnimalsChild, PreschoolFemaleFibrosisHumansMiceMiddle AgedTumor MicroenvironmentYoung AdultMetformin

Identifiers

PMID31597663
OpenAlexW2979808878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.